Parkinsonism Following Chimeric Antigen Receptor T Cell Therapy
Authors:
- 1 November 2024
- journal article
- editorial
- Published by American Medical Association (AMA) in JAMA Neurology
- Vol. 81 (11) , 1223-1224
Abstract
This case report describes a 67-year-old woman who had received adoptive immunotherapy with chimeric antigen receptor T cells for multiple myeloma and was experiencing parkinsonism-like symptoms.Keywords
This publication has 4 references indexed in Scilit:
- Neurologic toxicities following adoptive immunotherapy with BCMA-directed CAR T cellsBlood, 2023
- Chemotherapy-induced reversal of ciltacabtagene autoleucel–associated movement and neurocognitive toxicityBlood, 2023
- Incidence and management of CAR-T neurotoxicity in patients with multiple myeloma treated with ciltacabtagene autoleucel in CARTITUDE studiesBlood Cancer Journal, 2022
- Neurocognitive and hypokinetic movement disorder with features of parkinsonism after BCMA-targeting CAR-T cell therapyNature Medicine, 2021